Contract testing services supplier LabCorp has secured a credit facility with the Bank of America, citing capital expenditures and acquisitions among the potential uses of the funds.
AIT Bioscience says its new alliance with Perfinity Biosciences will provide protein analysis in 10 minutes, rather than the 48 hours that is standard across the industry.
LabCorp has finally been cleared to buy DNA testing services firm Orchid Cellmark after the US Federal Trade Commission (FTC) OKed the deal, albeit, with some conditions.
Quotient has stressed the importance of screening prototype formulations early in the development process to ensure efficient drug delivery in later phases.
Warnex’ pharmaceutical quality control (QC) contracting business continued to struggle in Q3, offsetting gains made by its trial laboratory services unit.
Quintiles says it will buy US bioanalytical lab Advion BioServices citing a pharmaceutical industry shift towards more thorough laboratory testing as motivation.
Almac hopes adding high potency API manufacturing capacity at its plant in Craigavon, Northern Ireland will help it retain early phase projects as they move to late-stage development.
SAFC announced its new aggressive growth strategy, including plans to expand in the developing markets, at its conference in Irvine, Glasgow last week.
SGS Life Sciences has added cell-based bioassays to the range of services available at its Poitiers, France, facility in what it says is part of its new aggressive growth strategy.
Esoterix Clinical Trials Services has forged a strategic alliance with the David H. Murdock Research Institute (DHMRI) to provide its clients with access to enhanced assay development services.
The growth seen in the early-phase contract development sector earlier this year may have stalled as pharmaceutical industry sponsors continue to hold off on expensive toxicology studies, according to new analysis.
The pharma biobanking and compound management services sector welcomed its newest member last week with Brooks Automation’s acquisition of Nexus Biosystems.
Quotient Amersham Radiochemicals has been rebranded as Quotient Custom Radiolabelling in the latest stage of two year expansion programme by parent Quotient Bioresearch.
Canadian lab services contractor Warnex posted improved results for Q1 with gains made by its bioanalytical unit offsetting a decline in its analytical services business.
EMD Millipore has opened a training facility in China as an education resource for the country’s rapidly expanding biopharmaceutical manufacturing and development sector.
Northern Ireland-based Almac Group has launched its selectAZyme brand, which provides a wide range of enzymes such as reductases, hydrolases, nitrolases for manufacturing applications.
Copley Scientific, the Nottingham, UK-based lab equipment manufacturer, has confirmed delivery of eight tablet dissolution testers to contract research organisation (CRO), Melbourn Scientific.
Wuxi PharmaTech finished the fourth quarter and the full year 2010 on a high driven by growth across all business units and the payoff from former suitor Charles River Laboratories (CRL).
Warnex will provide central laboratory services for Genzyme Canada as part of the US biotech’s lysosomal storage disease (LSD) testing programme in Canada.
QPS Holdings has acquired Taiwan’s Center of Toxicology and Preclinical Sciences (CTPS), continuing its expansion in the region’s rapidly expanding drug development sector.
Solvias says its new combined corporate office and analytical lab in Kaiseraugst, Switzerland will improve the speed and efficiency of its contract analysis services.
An agreement to provide exclusive toxicology services, pharmaceutical analysis and bioanalytical services are at the heart of a new partnership signed by life sciences company Bioanalytical Systems (BASi) and clinical-stage pharmaceutical company Pharmasset.
Outsourcing-Pharma presents a round up five of our top articles on strategic partnering, which continued apace in 2010, including deals by Covance, PPD and Parexel.
Caliper Life Sciences has begun toxicity testing on the final 350 compounds covered by the US Environmental protection Agency’s (EPA) ToxCast screening programme.
the exponential growth of data points flowing into clinical study databases. As technologies help researchers to reach more patients all over the world,...
Solvents are defined as organic chemicals that are used to dissolve components. They are used during the manufacture of drug substances and can also potentially...